Application of bioassay panel for assessing the impact of advanced oxidation processes on the treatment of reverse osmosis brine

Journal of Chemical Technology and Biotechnology

Volumn 89, Issue 8, 2014, Pages 1168-1174

  Justo, Ana ^a   González, Óscar ^a   Aceña, Jaume ^b   Mita, Luigi ^b,d   Casado, Marta ^b   Pérez, Sandra ^b   Piña, Benjamín ^b   Sans, Carme ^a   Barceló, Damià ^b,c   Esplugas, Santiago ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

^c UNIVERSITY OF GIRONA   (Spain)

^d INBB National Laboratory on Endocrine Disruptors   (Italy)

Author keywords

AOP; Bioassay; Micropollutants; RO brine; RYA

Indexed keywords

CHEMICAL ANALYSIS; ORGANIC POLLUTANTS; OZONE; OZONIZATION; REVERSE OSMOSIS; WATER POLLUTION;

ADVANCED OXIDATION PROCESSES; ADVANCED WATER TREATMENT PROCESS; AOP; DIOXIN-LIKE ACTIVITIES; DIOXIN-LIKE COMPOUNDS; ESTROGENIC ACTIVITIES; MICROPOLLUTANTS; RYA;

BIOASSAY;

ATENOLOL; CARBAMAZEPINE; CLARITHROMYCIN; COTRIMOXAZOLE; DIAZEPAM; DICLOFENAC; DIOXIN; HYDROGEN PEROXIDE; KETOPROFEN; LORAZEPAM; NAPROXEN; OZONE; TRIMETHOPRIM;

ALKALINITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOASSAY; BIODEGRADABILITY; CHEMICAL ANALYSIS; LIQUID CHROMATOGRAPHY; OXIDATION; OZONATION; POLLUTANT; REVERSE OSMOSIS; REVERSE OSMOSIS BRINE; TANDEM MASS SPECTROMETRY; ULTRAVIOLET RADIATION; WASTE WATER; WASTE WATER MANAGEMENT; WATER QUALITY;

EID: 84903974388     PISSN: 02682575     EISSN: 10974660     Source Type: Journal    
DOI: 10.1002/jctb.4389     Document Type: Article

References (32)

1. Onesios KM, Yu JT and Bouwer EJ, Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review. Biodegradation 20:441-466 (2009).
2. Westerhoff P, Moon H, Minakata D and Crittenden J, Oxidation of organics in retentates from reverse osmosis wastewater reuse facilities. Water Res 43:3992-3998 (2009).
3. Bagastyo AY, Keller J, Poussade Y and Batstone DJ, Characterization and removal of recalcitrants in reverse osmosis concentrates from water reclamation plants. Water Res 45:2415-2427 (2011).
4. Pérez-González A, Urtiaga AM, Ibáñez R and Ortiz I, State of the art and review on the treatment technologies of water reverse osmosis concentrates. Water Res 46:267-283 (2012).
5. Dialynas E, Mantzavinos D and Diamadopoulos E, Advanced treatment of the reverse osmosis concentrate produced during reclamation of municipal wastewater. Water Res 42:4603-4608 (2008).
6. Abdelmelek SB, Greaves J, Ishida KP, Cooper WJ and Song W, Removal of pharmaceutical and personal care products from reverse osmosis retentate using advanced oxidation processes. Environ Sci Technol 45:3665-3671 (2011).
7. 2 and ozone. J Hazard Mater 263:268-274 (2013).
8. Andrews JM, Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48 Suppl 1:5-16 (2001).
9. Akbar A, Anal AK and Ansari FA, Prevalence and antibiogram study of Salmonella and Staphylococcus aureus in poultry meat. Asian Pacific J Tropical Biomed 3:163-168 (2013).
10. Varela AR and Manaia CM, Human health implications of clinically relevant bacteria in wastewater habitats. Environ Sci Pollut Res Int 20:3550-3569 (2013).
11. Garcia-Reyero N, Grau E, Castillo M, De Alda MJL, Barceló D and Piña B, Monitoring of endocrine disruptors in surface waters by the yeast recombinant assay. Environ Toxicol Chem 20:1152-1158 (2001).
12. Miller CA, Expression of the human aryl hydrocarbon receptor complex in yeast. Activation of transcription by indole compounds. J Biol Chem 272:32824-32829 (1997).
13. Noguerol T, Boronat S, Casado M, Raldúa D, Barceló D and Piña B, Evaluating the interactions of vertebrate receptors with persistent pollutants and antifouling pesticides using recombinant yeast assays. Anal Bioanal Chem 385:1012-1019 (2006).
14. Hankinson O, The aryl hydrocarbon receptor complex. Ann Rev Pharmacol Toxicol 35:307-340 (1995).
15. Nebert DW, Puga A and Vasiliou V, Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann N Y Acad Sci 685:624-640 (1993).
16. Noguerol T, Boronat S, Jarque S, Barceló D and Pina B, Detection of hormone receptor ligands in yeast by fluorogenic methods. Talanta 69:351-358 (2006).
17. Auriol M, Filali-Meknassi Y, Adams CD, Tyagi RD, Noguerol TN and Piña B, Removal of estrogenic activity of natural and synthetic hormones from a municipal wastewater: efficiency of horseradish peroxidase and laccase from Trametes versicolor. Chemosphere 70:445-452 (2008).
18. Ávila C, Matamoros V, Reyes-Contreras C, Piña B, Casado M, Mita L, Rivetti C, Barata C, García J and Bayona JM, Attenuation of emerging organic contaminants in a hybrid constructed wetland system under different hydraulic loading rates and their associated toxicological effects in wastewater. Sci Total Environ 470-471:1272-1280 (2014).
19. 2 oxidation of deca-bromo diphenyl ether in sediments. Sci Total Environ 17-20:479-480 (2014).
20. 2 in photo-Fenton reactions using metavanadate. Talanta 66:86-91(2005).
21. Standard Methods for the Examination of Water and Wastewater, 21st edn. American Public Health Association/American Water Works Association/Water Pollution Control Federation, Washington, DC, USA (2005).
22. Gros M, Rodríguez-Mozaz S and Barceló D, Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J Chromatogr A 1248:104-121 (2012).
23. Benner J, Salhy E, Ternes T and von Gunten U, Ozonation of reverse osmosis concentrate: kinetics and efficiency of beta blocker oxidation. Water Res 42:3003-3012 (2008).
24. Oulton RL, Kohn T and Cwiertny DM, Pharmaceuticals and personal care products in effluent matrices: a survey of transformation and removal during wastewater treatment and implications for wastewater management. J Environ Monit 12:1956-1978 (2010).
25. 2 treatment for the oxidation of pharmaceuticals in wastewater. Water Res 44:1440-1448 (2010).
26. 2 treatment of reverse osmosis concentrate produced from municipal wastewater reclamation. Water Res 46:3229-3239 (2012).
27. 2 for reducing organic matter from highly saline reverse osmosis concentrate produced from municipal wastewater reclamation. Chemosphere 93:683-688 (2013).
28. Gunnarsson L, Kristiansson E, Rutgersson C, Sturve J, Fick J, Forlin L and Larsson DGJ, Pharmaceutical industry effluent diluted 1:500 affects global gene expression, cytochrome p450 1A activity, and plasma phosphate in fish. Environ Toxicol Chem 28:2639-2647 (2009).
29. Olivares A, Quiros L, Pelayo S, Navarro A, Bosch C, Grimalt JO, Fabregat MC, Faria M, Benejam L, Benito J, Sole M, Barata C and Piña B, Integrated biological and chemical analysis of organochlorine compound pollution and of its biological effects in a riverine system downstream the discharge point. Sci Total Environ 408:5592-5599 (2010).
30. Misaki K, Kawami H, Tanaka T, Handa Y, Nakamura M, Matsui S and Matsuda T, Aryl hydrocarbon receptor ligand activity of polycyclic aromatic ketones and polycyclic aromatic quinones. Environ Toxicol Chem 26:1370-1379 (2007).
31. Chamorro S, Hernandez V, Matamoros V, Dominguez C, Vidal G, Piña B and Bayona JM, Chemical characterization of organic microcontaminant sources and biological effects in riverine sediments impacted by urban sewage and pulp mill discharges. Chemosphere 90:611-619 (2013).
32. Boronat S, García-Reyero N, Fonts R, Fernández P, Grimalt JO and Piña B, Biological activity of aryl hydrocarbon receptor ligands in sediments from remote European lakes. Freshwater Biol 54:2543-2554 (2009).